PGP39
3508
Dr.Lekha Ravikumar
| Membership No | Author Name | Mobile | |
|---|---|---|---|
| 4607MW | Dr.Supritha K B | suprithakb19977@gmail.com | 8618374560 |
Cornea, Ocular Surface and External Eye Diseases
Povidone-iodine-loteprednol vs moxifloxacin dexamethasone in adenoviral conjunctivitis
Purpose :Adenoviral conjunctivitis is a common, highly contagious ocular infection with limited effective treatment options. This study compared the safety and efficacy of topical povidone-iodine (PVP-I) 0.6%/loteprednol 0.5% and moxifloxacin 0.5%/dexamethasone 0.1%. Methods:A prospective interventional comparative study was conducted from December 2025 to June 2026 in 58 patients aged >12 years with clinically diagnosed adenoviral conjunctivitis. Patients were alternately allocated to receive either regimen four times daily. Assessments were performed on day 3, week 1, and month 1. Safety, efficacy, and time to clinical resolution were compared. Results:PVP-I/loteprednol showed earlier clinical resolution (6–9 days) compared with moxifloxacin/dexamethasone (1–2 weeks). Both regimens were well tolerated. Conclusion:PVP-I 0.6%/loteprednol0.5% was well tolerated and associated with earlier clinical resolution compared with moxifloxacin 0.5%/dexamethasone0.1% in adenoviral conjunctivitis.
| Membership No | Author Name | Mobile | |
|---|---|---|---|
| 3791 | Dr.Chaithra C M | chaithracm08@gmail.com | 9035268295 |